Cramer, Christina K.
Cummings, Tiffany L.
Andrews, Rachel N.
Strowd, Roy
Rapp, Stephen R.
Shaw, Edward G.
Chan, Michael D.
Lesser, Glenn J.
Article History
First Online: 8 April 2019
Compliance with Ethical Standards
:
: Christina K. Cramer has received speaker’s honoraria from Monteris Medical, and is also a member of teaching faculty for an on-site SBRT training course to which Elekta refers customers and for which Elekta reimburses the department.Tiffany L. Cummings declares that she has no conflict of interest.Rachel N. Andrews declares that she has no conflict of interest.Michael Chan has received speaker’s honoraria from Monteris Medical, and is also a member of teaching faculty for an on-site SBRT training course to which Elekta refers customers and for which Elekta reimburses the department.Roy Strowd declares that he has no conflict of interest.Stephen R. Rapp declares that he has no conflict of interest.Edward G. Shaw declares that he has no conflict of interest.Glenn J. Lesser has received clinical trial support from Vascular Biogenics, Incyte, NewLink Genetics, Novartis, Immunocellular Therapeutics, and Pfizer; has received compensation from Monteris Medical and Insys Therapeutics for service as a consultant; and has received compensation from Stemline Therapeutics for serving as Data Safety and Monitoring Board Chair for a study.
: This article does not contain any studies with human or animal subjects performed by any of the authors.